Haematopoietic stem cells (blood stem cells) are responsible for the regeneration of blood cells with their various tasks, e.g. oxygen transport, wound closure and immune defence.
Haematopoietic stem cell preparations are obtained from blood in circulation, from bone marrow or from cord blood and then placed in an anticoagulant solution. They are used fresh or are deep-frozen at temperatures below -140°C; for stem cell transplantation, stem cell preparations from the patient (autologous) or obtained from a donor (allogeneic) can be used.
Search results 176 to 200 from a total of 355
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
DUS directed HPC(A) |
Universitätsklinikum Düsseldorf |
PEI.G.03993.01.1 | 06.06.2011 | |
|
DUS directed HPC(A) cryopreserved |
Universitätsklinikum Düsseldorf |
PEI.G.03993.02.1 | 06.06.2011 | |
|
DUS directed HPC(M) |
Universitätsklinikum Düsseldorf |
PEI.G.03995.01.1 | 21.12.2011 | |
|
DUS directed HPC(M) MNC enriched |
Universitätsklinikum Düsseldorf |
PEI.G.03995.02.1 | 21.12.2011 | |
|
Erythrozytendepletierte Stammzellen aus KM FAU allogen gerichtet |
Universitätsklinikum Erlangen |
PEI.G.03828.02.1 | 28.12.2011 | |
|
Gerichtete humane allogene periphere Blutstammzellen - Cellex |
Cellex Gesellschaft für Zellgewinnung mbH |
PEI.G.03670.01.1 | 17.11.2009 | |
Gerichtete humane allogene periphere Blutstammzellen - DKMS Collection Center |
DKMS Collection Center gGmbH, Tübingen |
PEI.G.12144.01.1 | 22.02.2023 | |
|
HemoCord |
Bayerische Stammzellbank gGmbH |
PEI.H.03065.01.1 | 18.08.2007 | |
|
HemoCord-S |
Bayerische Stammzellbank gGmbH |
PEI.H.03065.02.1 | 03.06.2011 | |
|
HPC-A al Hämatopoetische Progenitorzellen eines allogenen Spenders aus Apherese (UKSH) |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03674.01.1 | 27.12.2010 | |
|
HPC-A alkr Hämatopoetische Progenitorzellen eines allogenen Spenders aus Apherese (UKSH) kryokonserviert |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03674.02.1 | 27.12.2010 | |
|
HPC-A allo GÖ |
Georg-August-Universität Göttingen |
PEI.G.04090.01.1 | 16.09.2011 | |
|
HPC-A allo GÖ kryo |
Georg-August-Universität Göttingen |
PEI.G.04090.02.1 | 16.09.2011 | |
|
HPC-A allo GÖ selek |
Georg-August-Universität Göttingen |
PEI.G.04090.03.1 | 16.09.2011 | |
|
HPC-A allo GÖ selek kryo |
Georg-August-Universität Göttingen |
PEI.G.04090.04.1 | 16.09.2011 | |
|
HPC-A alsel Hämatopoetische Progenitorzellen eines allogenen Spenders aus Apherese (UKSH) CD34+selektioniert |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03674.03.1 | 27.12.2011 | |
|
HPC-A alselkr Hämatopoetische Progenitorzellen eines allogenen Spenders aus Apherese (UKSH) CD34+selektioniert, kryokonserviert |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03674.04.1 | 27.12.2011 | |
|
HPC-A auto GÖ kryo |
Universitätsmedizin Göttingen |
PEI.G.04091.01.1 | 04.07.2011 | |
|
HPC-A auto GÖ selek kryo |
Universitätsmedizin Göttingen |
PEI.G.04091.02.1 | 04.07.2011 | |
|
HPC-A Hämatopoetische Progenitorzellen eines autologen Spenders aus Apherese (UKSH) |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03673.01.1 | 22.12.2011 | |
|
HPC-A kr Hämatopoetische Progenitorzellen eines autologen Spenders aus Apherese (UKSH) kryokonserviert |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03673.02.1 | 22.12.2011 | |
|
HPC-A selkr Hämatopoetische Progenitorzellen eines autologen Spenders aus Apherese (UKSH) CD34+ selektioniert, kryokonserviert |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03673.03.1 | 22.12.2011 | |
|
HPC-BM allo GÖ |
Georg-August-Universität Göttingen |
PEI.G.04088.01.1 | 22.12.2011 | |
|
HPC-BM auto GÖ |
Georg-August-Universität Göttingen |
PEI.G.04089.01.1 | 03.01.2012 | |
|
HPC-M al Hämatopoetische Progenitorzellen eines allogenen Spenders aus Knochenmark (UKSH) |
Universitätsklinikum Schleswig-Holstein |
PEI.G.03672.01.1 | 19.01.2012 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 518 in BAnz AT 26.06.2024 B7.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 26.06.2024
